Home / Industry / Pharmaceuticals & Biotechnology / Vaccine Adjuvants Market

Vaccine Adjuvants Market

Global Vaccine Adjuvants Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Product Type, By Route of Administration, By Disease Type, By Application, By Vaccine Type, By End User, By Geographic Coverage and By Company)

Published Date: Jan 2025 | Format: | No. of Pages: 182

Industry: Pharmaceuticals & Biotechnology | Author Name: Sayali

Request Customisation / Information

  
$4,995.00
Buy now
Report Description Research Methodology

FAQ : Vaccine Adjuvants Market

The vaccine adjuvants industry is estimated to be valued at US$ 1.69 Bn in 2025.

North America is projected to account for the largest market share in 2025.

The industry is estimated to rise at a CAGR of 14.3% from 2025 to 2032.

Pfizer Inc., GlaxoSmithKline plc, and AstraZeneca are few of the key contributors.

Rising prevalence of influenza and government investments in healthcare are key enablers.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services